Showing results (101-110 of 254) with videos related to
Sort By:
Pageof 26
British Journal of Haematology|May 29, 2010
Improved survival for relapsed diffuse large B cell lymphoma is predicted by a negative pre-transplant FDG-PET scan following salvage chemotherapyMichael Dickinson, Rosemary Hoyt, Andrew W Roberts, et al.Leukemia Research|August 20, 2010
Alloreactive natural killer cells in hematopoietic stem cell transplantationHollie J Pegram, David S Ritchie, Mark J Smyth, et al.Cancer|September 17, 2004
A new model for predicting infectious complications during fludarabine-based combination chemotherapy among patients with indolent lymphoid malignanciesConstantine S Tam, Max M Wolf, E Henry Januszewicz, et al.International Journal of Radiation Oncology, Biology, Physics|November 29, 2008
Impact of 18F-fluorodeoxyglucose positron emission tomography before and after definitive radiation therapy in patients with apparently solitary plasmacytomaPaul J Kim, Rodney J Hicks, Andrew Wirth, et al.Cancer|March 23, 2011
Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entityMelissa G Lechner, Stephen Lade, Daniel J Liebertz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2010
Phase III placebo-controlled trial of denileukin diftitox for patients with cutaneous T-cell lymphomaH Miles Prince, Madeleine Duvic, Ann Martin, et al.International Journal of Radiation Oncology, Biology, Physics|July 15, 2025
Radiation Therapy Utilization for Primary Cutaneous T-Cell Lymphoma Is Lowest Among Patients Living in the Most Geographically Accessible Areas: An Australian StudyBelinda A Campbell, Gabriel Gabriel, Geoff P Delaney, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 1, 2022
Excellent treatment outcomes from low dose radiation therapy for primary cutaneous CD4+ small/medium T-Cell lymphoproliferative disorderJennifer Ward, H Miles Prince, Chris McCormack, et al.Leukemia & Lymphoma|July 16, 2005
Ante-mortem diagnosis of localized invasive esophageal aspergillosis in a patient with acute myeloid leukemiaFiona Chionh, Kirsten E Herbert, John F Seymour, et al.Cancer|May 2, 2006
Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-Hodgkin lymphomaConstantine S Tam, Max Wolf, H Miles Prince, et al.Pageof 26